rs554718345
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Uncertain significance. The variant received 2 ACMG points: 2P and 0B. PM2
The NM_021098.3(CACNA1H):c.2061C>A(p.Ser687Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar. Synonymous variant affecting the same amino acid position (i.e. S687S) has been classified as Likely benign.
Frequency
Genomes: not found (cov: 33)
Exomes 𝑓: 0.0 ( 0 hom. )
Failed GnomAD Quality Control
Consequence
CACNA1H
NM_021098.3 missense
NM_021098.3 missense
Scores
2
10
7
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 0.831
Publications
1 publications found
Genes affected
CACNA1H (HGNC:1395): (calcium voltage-gated channel subunit alpha1 H) This gene encodes a T-type member of the alpha-1 subunit family, a protein in the voltage-dependent calcium channel complex. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization and consist of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. The alpha-1 subunit has 24 transmembrane segments and forms the pore through which ions pass into the cell. There are multiple isoforms of each of the proteins in the complex, either encoded by different genes or the result of alternative splicing of transcripts. Alternate transcriptional splice variants, encoding different isoforms, have been characterized for the gene described here. Studies suggest certain mutations in this gene lead to childhood absence epilepsy (CAE). [provided by RefSeq, Jul 2008]
CACNA1H Gene-Disease associations (from GenCC):
- hyperaldosteronism, familial, type IVInheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- childhood absence epilepsyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- epilepsy, childhood absence, susceptibility to, 6Inheritance: AD Classification: LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Uncertain_significance. The variant received 2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| CACNA1H | NM_021098.3 | c.2061C>A | p.Ser687Arg | missense_variant | Exon 10 of 35 | ENST00000348261.11 | NP_066921.2 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| CACNA1H | ENST00000348261.11 | c.2061C>A | p.Ser687Arg | missense_variant | Exon 10 of 35 | 1 | NM_021098.3 | ENSP00000334198.7 | ||
| CACNA1H | ENST00000569107.6 | c.2061C>A | p.Ser687Arg | missense_variant | Exon 10 of 34 | 1 | ENSP00000454990.2 | |||
| CACNA1H | ENST00000711493.1 | c.2061C>A | p.Ser687Arg | missense_variant | Exon 10 of 34 | ENSP00000518778.1 | ||||
| CACNA1H | ENST00000565831.7 | c.2061C>A | p.Ser687Arg | missense_variant | Exon 10 of 34 | 1 | ENSP00000455840.1 | |||
| CACNA1H | ENST00000711450.1 | c.2061C>A | p.Ser687Arg | missense_variant | Exon 10 of 35 | ENSP00000518762.1 | ||||
| CACNA1H | ENST00000564231.6 | c.2061C>A | p.Ser687Arg | missense_variant | Exon 10 of 35 | 1 | ENSP00000457555.2 | |||
| CACNA1H | ENST00000638323.1 | c.2022C>A | p.Ser674Arg | missense_variant | Exon 10 of 35 | 5 | ENSP00000492267.1 | |||
| CACNA1H | ENST00000562079.6 | c.2061C>A | p.Ser687Arg | missense_variant | Exon 10 of 34 | 1 | ENSP00000454581.2 | |||
| CACNA1H | ENST00000711438.1 | c.2022C>A | p.Ser674Arg | missense_variant | Exon 10 of 34 | ENSP00000518754.1 | ||||
| CACNA1H | ENST00000711482.1 | c.2061C>A | p.Ser687Arg | missense_variant | Exon 10 of 36 | ENSP00000518771.1 | ||||
| CACNA1H | ENST00000711485.1 | c.2061C>A | p.Ser687Arg | missense_variant | Exon 10 of 35 | ENSP00000518774.1 | ||||
| CACNA1H | ENST00000711455.1 | c.2061C>A | p.Ser687Arg | missense_variant | Exon 10 of 36 | ENSP00000518768.1 | ||||
| CACNA1H | ENST00000711483.1 | c.2061C>A | p.Ser687Arg | missense_variant | Exon 10 of 35 | ENSP00000518772.1 | ||||
| CACNA1H | ENST00000711456.1 | c.2061C>A | p.Ser687Arg | missense_variant | Exon 10 of 34 | ENSP00000518769.1 | ||||
| CACNA1H | ENST00000621827.2 | n.2061C>A | non_coding_transcript_exon_variant | Exon 10 of 37 | 6 | ENSP00000518766.1 | ||||
| CACNA1H | ENST00000637236.3 | n.2061C>A | non_coding_transcript_exon_variant | Exon 10 of 34 | 5 | ENSP00000492650.2 | ||||
| CACNA1H | ENST00000639478.1 | n.2061C>A | non_coding_transcript_exon_variant | Exon 10 of 35 | 5 | ENSP00000491945.1 | ||||
| CACNA1H | ENST00000640028.1 | n.1444C>A | non_coding_transcript_exon_variant | Exon 10 of 35 | 5 | ENSP00000491488.1 | ||||
| CACNA1H | ENST00000711442.1 | n.*1508C>A | non_coding_transcript_exon_variant | Exon 9 of 34 | ENSP00000518758.1 | |||||
| CACNA1H | ENST00000711448.1 | n.2061C>A | non_coding_transcript_exon_variant | Exon 10 of 36 | ENSP00000518760.1 | |||||
| CACNA1H | ENST00000711449.1 | n.2061C>A | non_coding_transcript_exon_variant | Exon 10 of 35 | ENSP00000518761.1 | |||||
| CACNA1H | ENST00000711451.1 | n.2061C>A | non_coding_transcript_exon_variant | Exon 10 of 36 | ENSP00000518763.1 | |||||
| CACNA1H | ENST00000711452.1 | n.2061C>A | non_coding_transcript_exon_variant | Exon 10 of 36 | ENSP00000518764.1 | |||||
| CACNA1H | ENST00000711453.1 | n.2061C>A | non_coding_transcript_exon_variant | Exon 10 of 36 | ENSP00000518765.1 | |||||
| CACNA1H | ENST00000711484.1 | n.2061C>A | non_coding_transcript_exon_variant | Exon 10 of 35 | ENSP00000518773.1 | |||||
| CACNA1H | ENST00000711486.1 | n.2061C>A | non_coding_transcript_exon_variant | Exon 10 of 37 | ENSP00000518775.1 | |||||
| CACNA1H | ENST00000711487.1 | n.2061C>A | non_coding_transcript_exon_variant | Exon 10 of 36 | ENSP00000518776.1 | |||||
| CACNA1H | ENST00000711488.1 | n.2061C>A | non_coding_transcript_exon_variant | Exon 10 of 35 | ENSP00000518777.1 | |||||
| CACNA1H | ENST00000711442.1 | n.*1508C>A | 3_prime_UTR_variant | Exon 9 of 34 | ENSP00000518758.1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 genomes
Cov.:
33
GnomAD4 exome Data not reliable, filtered out with message: AC0 AF: 0.00 AC: 0AN: 1448588Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 719476
GnomAD4 exome
Data not reliable, filtered out with message: AC0
AF:
AC:
0
AN:
1448588
Hom.:
Cov.:
32
AF XY:
AC XY:
0
AN XY:
719476
African (AFR)
AF:
AC:
0
AN:
33218
American (AMR)
AF:
AC:
0
AN:
43378
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
25864
East Asian (EAS)
AF:
AC:
0
AN:
39124
South Asian (SAS)
AF:
AC:
0
AN:
84096
European-Finnish (FIN)
AF:
AC:
0
AN:
50622
Middle Eastern (MID)
AF:
AC:
0
AN:
5752
European-Non Finnish (NFE)
AF:
AC:
0
AN:
1106666
Other (OTH)
AF:
AC:
0
AN:
59868
GnomAD4 genome Cov.: 33
GnomAD4 genome
Cov.:
33
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Uncertain
DANN
Uncertain
DEOGEN2
Benign
T;.;.;.
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
T;T;T;.
M_CAP
Pathogenic
D
MetaRNN
Uncertain
T;T;T;T
MetaSVM
Uncertain
D
MutationAssessor
Uncertain
M;.;M;M
PhyloP100
PrimateAI
Uncertain
T
PROVEAN
Benign
N;.;N;N
REVEL
Uncertain
Sift
Uncertain
D;.;D;D
Sift4G
Benign
T;.;T;T
Polyphen
D;.;D;D
Vest4
MutPred
Loss of glycosylation at S687 (P = 0.0094);.;Loss of glycosylation at S687 (P = 0.0094);Loss of glycosylation at S687 (P = 0.0094);
MVP
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.